M&A Corner
DNA company Asa Ren raises $8M and more briefs11 Feb 2023
Indonesian DNA data firm Asa Ren scores $8M funding Asa Ren, one of the first DNA data companies in Indonesia,... Continue Reading
|
Southeast Asian online pharma SwipeRx gets $10 million from Sanofi, other investors11 Feb 2023
Online pharmacy platform SwipeRx has received $10 million in additional Series B funding from marquee investors, including Sanofi’s Global Health... Continue Reading
|
Faro Health Secures $20M to Streamline Smart Clinical Trials11 Feb 2023
– Faro Health, a cloud-computing company that is developing digital infrastructure for smart clinical trials raises $20M in Series A... Continue Reading
|
OCD-focused platform NOCD raises $35M and more digital health fundings11 Feb 2023
Digital obsessive-compulsive disorder (OCD) identification and management platform NOCD closed a $35 million funding round co-led by Cigna Ventures and... Continue Reading
|
Included Health, Solv Partner to Connect Virtual & In-Person Care11 Feb 2023
– Solv today announced the launch of Solv Final Mile Network, the first solution to bridge the gap from online... Continue Reading
|
Global pharma solutions partner Envision Pharma will add OKRA.ai to its platform this month, building on its suite of pharma applications.11 Feb 2023
– This week, Envision Pharma Group announced that it had acquired OKRA.ai, a leader in artificial intelligence solutions for pharmaceutical... Continue Reading
|
Globus Medical to Merge With NuVasive In $3.1Bn All-Stock Deal Analysts Foresee Challenges11 Feb 2023
Executive Summary Analysts from Piper Sandler and BTIG noted that the proposed merger between Globus Medical and NuVasive raises concerns... Continue Reading
|
How pharma partnerships could benefit digital therapeutics companies11 Feb 2023
At the tail end of 2022, Click Therapeutics announced it was expanding its partnership with Boehringer Ingelheim focused on developing... Continue Reading
|
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC11 Feb 2023
CFIUS clearance represents the final required regulatory approval to complete the proposed merger Completion remains subject to the approval of... Continue Reading
|
Avania Acquires MAXIS, Advancing MedTech Leadership in Pre-Clinical, Regulatory Strategy, and Clinical Expertise11 Feb 2023
BILTHOVEN, Netherlands–(BUSINESS WIRE)– Avania, a leading, global medical technology contract research organization (CRO), today announced its acquisition of MAXIS, a... Continue Reading
|